Top Markets
#1 SAFEcoin SAFEcoin +32.96%
#2 Zora Zora +29.49%
#3 AI XOVIA AI XOVIA +22.03%
#4 Helium Helium +21.85%
#5 Full Moon Full Moon +19.85%
#6 Merlin's Seal BTC Merlin's Seal BTC +16.10%
#7 0G 0G +15.13%
#8 Axelar Axelar +14.88%
#9 Bless Bless +13.79%
#10 VVS Finance VVS Finance +13.70%
Coin of the day
SAFEcoin SAFEcoin
Settings
Language
ENGLISH
Currency
USD
Theme
Graphite Bio, Inc. Graphite Bio, Inc.

Graphite Bio, Inc.

GRPH
Rank in Stocks #12751
Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to... Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the glucocerebrosidase enzyme. Initially established as Integral Medicines, Inc., the company rebranded to Graphite Bio, Inc. in August 2020. Founded in 2017, Graphite Bio's operations are based out of its headquarters in South San Francisco, California.
Share Price
$22.26
Last synced: 2024-03-22
Market Cap
$553.40M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Graphite Bio, Inc. (GRPH)

Category

Healthcare
Stock split history for Graphite Bio, Inc. (GRPH)
Graphite Bio, Inc. stock (symbol: GRPH) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 31, 2026.
One GRPH share bought prior to Aug 31, 2026 would equal to 0 GRPH shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH